...
首页> 外文期刊>European review for medical and pharmacological sciences. >3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition, migration and invasion in endometrial stromal cells by inhibiting the Notch signaling pathway
【24h】

3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition, migration and invasion in endometrial stromal cells by inhibiting the Notch signaling pathway

机译:3,6-二羟基黄酮通过抑制Notch信号通路抑制子宫内膜间质细胞的上皮-间质转化,迁移和侵袭

获取原文
           

摘要

OBJECTIVE: Endometriosis is a common disease in women of reproductive age. Characteristics of endometriosis include invasion, metastasis, and recurrence, which are similar to those of malignant tumors. However, the etiology and pathogenesis of endometriosis are still not clear. This study aims to explore the mechanism of 3,6-dihydroxyflavone (3,6-DHF) in the development of endometriosis. PATIENTS AND METHODS: Primary cultured ovarian ectopic endometrial stromal cells (OvESCs) were utilized as the in vitro model of endometriosis. OvESCs were treated with different concentrations of 3,6-DHF. The expressions of proteins related to epithelial-mesenchymal transition (EMT) and Notch signal pathway were detected by Western blot. The mRNA expressions of related genes were detected by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). The viability of treated cells was detected by transwell assay. The impact of 3,6-DHF on ectopic lesions was explored after the animal model of endometriosis was successfully established. RESULTS: With the increased concentration of 3,6-DHF in OvESCs, the protein and mRNA expressions of E-cadherin were gradually increased, while the protein and mRNA expressions of N-cadherin, Twist, Snail, and Slug were decreased. 3,6-DHF treatment inhibited the migration and invasion ability of OvESCs in a dose-dependent manner. In the endometriosis model of severe combined immunodeficient (SCID) mice, lesions in the 3,6-DHF treated group were significantly smaller than those of the control group. The same changes were found in the endometriosis model of Sprague Dawley (SD) rats. Protein expressions of Notch1, NICD, and Hes-1 in OvESCs were inhibited by 3,6-DHF in a dose-dependent manner. 3,6-DHF can inhibit the binding of NICD-CSL-MAML complex in OvESCs, thereby inhibiting the expressions of proteins related to Notch signaling pathway in vitro. CONCLUSIONS: 3,6-DHF can inhibit the development of EMT, migration, and invasion of endometrial stromal cells by inhibiting the Notch signaling pathway.
机译:目的:子宫内膜异位症是育龄妇女的常见病。子宫内膜异位的特征包括浸润,转移和复发,这与恶性肿瘤相似。但是,子宫内膜异位的病因和发病机制仍不清楚。本研究旨在探讨3,6-二羟基黄酮(3,6-DHF)在子宫内膜异位症发展中的作用机制。病人和方法:原代培养的卵巢异位子宫内膜基质细胞(OvESCs)被用作子宫内膜异位症的体外模型。 OvESCs用不同浓度的3,6-DHF处理。 Western blot检测上皮间质转化(EMT)和Notch信号通路相关蛋白的表达。通过定量实时聚合酶链反应(qRT-PCR)检测相关基因的mRNA表达。通过transwell测定法检测处理的细胞的活力。成功建立子宫内膜异位症动物模型后,探讨了3,6-DHF对异位病变的影响。结果:随着OvESCs中3,6-DHF浓度的升高,E-cadherin的蛋白和mRNA表达逐渐升高,而N-cadherin,Twist,Snail和Slug的蛋白和mRNA表达降低。 3,6-DHF处理以剂量依赖性方式抑制OvESCs的迁移和侵袭能力。在严重的联合免疫缺陷(SCID)小鼠的子宫内膜异位症模型中,3,6-DHF治疗组的病变明显小于对照组。在Sprague Dawley(SD)大鼠的子宫内膜异位症模型中发现了相同的变化。 3,6-DHF以剂量依赖的方式抑制OvESCs中Notch1,NICD和Hes-1的蛋白表达。 3,6-DHF可以抑制OvESCs中NICD-CSL-MAML复合物的结合,从而在体外抑制Notch信号通路相关蛋白的表达。结论:3,6-DHF可以通过抑制Notch信号通路抑制EMT的发生,迁移和侵袭子宫内膜基质细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号